Dosing lamivudine or emtricitabine in renal impairment: new data confirm it's time for updated guidance!

AIDS. 2021 Jul 1;35(8):1305-1307. doi: 10.1097/QAD.0000000000002903.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • Emtricitabine / therapeutic use
  • HIV Infections* / drug therapy
  • Humans
  • Kidney
  • Lamivudine / therapeutic use

Substances

  • Anti-HIV Agents
  • Lamivudine
  • Emtricitabine